In the present review, we summarize and discuss both the physiological actions of IL-18 in metabolism and its potential roles in pathophysiological mechanisms leading to the most common human metabolic disorders, such as obesity, diabetes and NAFLD/NASH. This evidence concerns the gene IL18 and obesity due to melanocortin 4 receptor deficiency.